Microarray Analysis Using Amplified mRNA from Laser Capture Microdissection of Microscopic Hepatocellular Precancerous Lesions and Frozen Hepatocellular Carcinomas Reveals Unique and Consistent Gene Expression Profiles

Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA.
Toxicologic Pathology (Impact Factor: 2.14). 05/2003; 31(3):295-303. DOI: 10.1080/01926230390204333
Source: PubMed


The indirect labeling cDNA microarray technique was used to evaluate gene expression profiles of pure cell populations from frozen sections of carcinomas and adenomas harvested from precancerous hepatocellular lesions by using laser capture microdissection (LCM). The levels of differentially expressed genes were investigated using a cDNA microarray with 9,984 features with only 2 ug of two-round amplified aRNA, equivalent to 35 cells from LCM-adenomas and frozen samples of carcinomas from simian virus 40 (SV40) large T antigen transgenic rats. A total of 855 genes were identified as being 3-fold or more differentially expressed in carcinomas or adenomas as compared to normal tissue controls. Among these 855 genes, 71 genes were differentially expressed in both carcinomas and adenomas. Commonly up-regulated genes in both carcinoma and adenomas were 28 while 41 of the 71 genes were commonly down-regulated. Two genes, Igh1 (immunoglobulin heavy chain 1(Serum IgG2a), Image clone ID: 875880) and EST clone (AI893585, Image clone ID: 596604) were more than 7-fold up-regulated in carcinomas and 6-fold down-regulated in adenomas. In Cy5 and Cy3 reciprocal experiments for screening out false positive signals, the amplified carcinomas showed higher Pearson Correlation Coefficient values (-0.94 and -0.92) than the LCM-amplified adenoma samples (-0.79 and -0.84). LCM-amplified samples provided higher signal intensities over backgrounds and a greater average of Cy5:Cy3 ratios. Expression levels of mRNAs from selected genes, determined by using traditional dot blot analysis, revealed that 36 of 40 tested expression profiles were consistent with the microarray data. Thus, amplified aRNA harvested from homogeneous cell types using LCM can be applied to study gene expression profiles by use of microarray analysis.

Download full-text


Available from: Peter Scacheri
  • Source
    • "This is most likely caused by the possible dilution of SV40-transformed cells with nontransformed cell types: LCM would ensure that RNA is only extracted from transformed enterocytes; villi fractionation would remove most of the muscle, mesenchyme, and crypt cells but still include goblet cells and enteroendocrine cells not expressing the SV40 T antigens; and SV40-transformed cells would be most dilute in whole intestine. LCM samples from liver were also shown to give more robust microarray ratios than samples obtained from dissected tissue (Yim et al., 2003). "
    [Show abstract] [Hide abstract]
    ABSTRACT: SV40 transforms cells through the action of two oncoproteins, large T antigen and small t antigen. Small t antigen targets phosphatase PP2A, while large T antigen stimulates cell proliferation and survival by action on multiple proteins, including the tumor suppressors Rb and p53. Large T antigen also binds components of the transcription initiation complex and several transcription factors. We examined global gene expression in SV40-transformed mouse embryo fibroblasts, and in enterocytes obtained from transgenic mice. SV40 transformation alters the expression of approximately 800 cellular genes in both systems. Much of this regulation is observed in both MEFs and enterocytes and is consistent with T antigen action on the Rb-E2F pathway. However, the regulation of many genes is cell-type specific, suggesting that unique signaling pathways are activated in different cell types upon transformation, and that the consequences of SV40 transformation depends on the type of cell targeted.
    Full-text · Article · Mar 2009 · Virology
  • Source
    • "On the other hand, analysis of the tumour tissue itself, both by classical biochemical methods and by microarray technology, provided inconsistent results. Some authors reported induction of CK expression in liver tumours ([37-39]; and, in part, [40]; M. Sakamoto and S. H. Yim, personal communication), others repression [41], and still others observed no statistically significant differences between normal and malignant liver tissue [11,30]. This may be a reflection of the diverse clinicopathological and biological phenotypes of HCC, with different underlying molecular defects. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Inconsistent findings have been reported on the occurrence and relevance of creatine kinase (CK) isoenzymes in mammalian liver cells. Part of this confusion might be due to induction of CK expression during metabolic and energetic stress. The specific activities and isoenzyme patterns of CK and adenylate kinase (AdK) were analysed in pathological liver tissue of patients undergoing orthotopic liver transplantation. The brain-type, cytosolic BB-CK isoenzyme was detected in all liver specimens analysed. Conversely, CK activity was strongly increased and a mitochondrial CK (Mi-CK) isoenzyme was detected only in tissue samples of two primary hepatocellular carcinomas (HCCs). The findings do not support significant expression of CK in normal liver and most liver pathologies. Instead, many of the previous misconceptions in this field can be explained by interference from AdK isoenzymes. Moreover, the data suggest a possible interplay between p53 mutations, HCC, CK expression, and the growth-inhibitory effects of cyclocreatine in HCC. These results, if confirmed, could provide important hints at improved therapies and cures for HCC.
    Preview · Article · Feb 2005 · BMC Gastroenterology
  • [Show abstract] [Hide abstract]
    ABSTRACT: To understand human pathology at the system level, one must examine the complex milieu of molecular interactions between various cells within human body, rather than the characteristics of isolated cell or cultured cell. However, all over the human body an understanding of the pathophysiology of particular tissues has lagged behind the insights in general biological processes. A “high-throughput revolution” unfolding in model clinical science leads to significant increase of knowledge describing transcriptome and proteome states in complex human diseases, including pathologies of the liver. Despite seeming accessibility of the profiling techniques, cautionary approach is necessary in the interpretation of the data. There are universal caveats that preclude meta-analysis of the data collected. Major biological obstacles are heterogeneity of the samples profiled, imperfect correlation between mRNA and protein levels, and normal variation in the levels of mRNAs and corresponding proteins in healthy individuals. Nevertheless, a significant gain in the understanding of NAFLD spectrum diseases reached recently is inseparable from the data accumulated in high-throughput projects.
    No preview · Article ·
Show more